Abbott India, the listed subsidiary of the US-based pharma giant, has outpaced its multinational peers to register a 14.6 per cent growth in sales to Rs 25.19 billion in nine months of the current financial. The growth has come at a time when GST implementation affected most Indian pharma companies ...
Read more: Abbott excels on power of brands, outpaces MNC peers on sales growth